US Stock MarketDetailed Quotes

CDTX Cidara Therapeutics

Watchlist
  • 13.0893
  • -0.0007-0.01%
Trading May 15 12:29 ET
59.71MMarket Cap-2517P/E (TTM)

Cidara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
21.22%-22.43M
39.42%-12.72M
-105.84%-1.63M
123.84%2.82M
53.84%-10.9M
-12.84%-28.47M
-40.89%-21M
333.65%27.97M
-444.07%-11.84M
-1,216.68%-23.61M
Net income from continuing operations
31.72%-22.93M
67.31%-5.61M
-154.56%-8.17M
5.81%-12.36M
117.55%3.21M
20.92%-33.58M
-2.14%-17.16M
182.83%14.98M
-222.48%-13.12M
0.06%-18.28M
Depreciation and amortization
-17.48%118K
34.48%39K
-40.54%22K
-19.55%-263K
7.74%320K
111.63%143K
101.41%29K
-87.33%37K
-182.71%-220K
12.93%297K
Other non cash items
26.27%1.24M
116.76%266K
-86.80%270K
-56.21%229K
47,400.00%475K
6,446.67%982K
-53,000.00%-1.59M
102,150.00%2.05M
8,616.67%523K
-75.00%1K
Change In working capital
-963.44%-3.92M
-179.05%-8.25M
-45.88%5.45M
4,674.17%14.42M
-123.21%-15.54M
-96.86%454K
-214.49%-2.96M
104.84%10.07M
103.59%302K
-145.35%-6.96M
-Change in receivables
-2,083.02%-10.41M
-1,592.92%-13.39M
1,351.43%2.63M
414.88%20.34M
-483.40%-19.99M
-108.20%-477K
46.70%-791K
70.63%-210K
225.59%3.95M
-130.70%-3.43M
-Change in inventory
---6.1M
---3.63M
---513K
----
----
--0
--0
--0
----
----
-Change in prepaid assets
253.07%3.74M
223.26%959K
-27.51%656K
186.25%1.25M
177.86%872K
-965.50%-2.44M
17.41%-778K
-63.89%905K
35.80%-1.45M
-342.95%-1.12M
-Change in payables and accrued expense
877.89%15.39M
251.90%9.19M
701.81%3.33M
78.42%-246K
374.28%3.12M
244.01%1.57M
1,025.89%2.61M
-153.94%-554K
28.08%-1.14M
359.68%657K
-Change in other current liabilities
7.51%-973K
17.82%-166K
35.74%-187K
-7.42%-304K
-14.49%-316K
-168.71%-1.05M
-109.35%-202K
-66.29%-291K
-21.98%-283K
-23.77%-276K
-Change in other working capital
-295.30%-5.56M
68.22%-1.21M
-104.58%-468K
-499.36%-4.67M
127.85%779K
-66.12%2.85M
-221.32%-3.8M
349.63%10.22M
34.92%-779K
-166.53%-2.8M
Cash from discontinued investing activities
Operating cash flow
21.22%-22.43M
39.42%-12.72M
-105.84%-1.63M
123.84%2.82M
53.84%-10.9M
-12.84%-28.47M
-40.89%-21M
333.65%27.97M
-444.07%-11.84M
-1,216.68%-23.61M
Investing cash flow
Cash flow from continuing investing activities
-327.97%-505K
-1,877.78%-178K
-1,300.00%-126K
-568.75%-107K
-11.90%-94K
-187.80%-118K
-9K
25.00%-9K
5.88%-16K
-600.00%-84K
Net PPE purchase and sale
-327.97%-505K
-1,877.78%-178K
-1,300.00%-126K
-568.75%-107K
-11.90%-94K
-187.80%-118K
---9K
25.00%-9K
5.88%-16K
-600.00%-84K
Cash from discontinued investing activities
Investing cash flow
-327.97%-505K
-1,877.78%-178K
-1,300.00%-126K
-568.75%-107K
-11.90%-94K
-187.80%-118K
---9K
25.00%-9K
5.88%-16K
-600.00%-84K
Financing cash flow
Cash flow from continuing financing activities
2,832.28%25.98M
-98.80%8K
0
76.51%-261K
4,394.11%26.24M
-102.13%-951K
-98.20%664K
113.21%107K
-225.25%-1.11M
-107.99%-611K
Net issuance payments of debt
--0
--0
--0
--0
--0
41.65%-2.59M
--0
66.61%-371K
0.00%-1.11M
0.00%-1.11M
Net common stock issuance
999.20%25.96M
-99.85%1K
--0
---261K
5,144.60%26.22M
-95.18%2.36M
-98.25%664K
298.01%1.2M
--0
-94.29%500K
Proceeds from stock option exercised by employees
--21K
--7K
--0
--0
--14K
--0
--0
--0
--0
--0
Net other financing activities
----
----
----
----
----
---720K
--0
----
----
----
Cash from discontinued financing activities
Financing cash flow
2,832.28%25.98M
-98.80%8K
--0
76.51%-261K
4,394.11%26.24M
-102.13%-951K
-98.20%664K
113.21%107K
-225.25%-1.11M
-107.99%-611K
Net cash flow
Beginning cash position
-47.44%32.73M
-8.30%48.67M
101.66%50.43M
26.35%47.98M
-47.44%32.73M
44.99%62.27M
31.69%53.08M
-52.90%25.01M
-22.18%37.97M
44.99%62.27M
Current changes in cash
110.31%3.05M
36.64%-12.89M
-106.27%-1.76M
118.93%2.45M
162.73%15.25M
-252.88%-29.54M
-192.62%-20.35M
319.41%28.07M
-400.77%-12.96M
-516.15%-24.3M
End cash Position
9.31%35.78M
9.31%35.78M
-8.30%48.67M
101.66%50.43M
26.35%47.98M
-47.44%32.73M
-47.44%32.73M
31.69%53.08M
-52.90%25.01M
-22.18%37.97M
Free cash flow
19.78%-22.94M
38.60%-12.9M
-106.29%-1.76M
122.91%2.72M
53.60%-10.99M
-13.13%-28.59M
-40.95%-21.01M
333.34%27.96M
-446.25%-11.85M
-1,212.58%-23.69M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 21.22%-22.43M39.42%-12.72M-105.84%-1.63M123.84%2.82M53.84%-10.9M-12.84%-28.47M-40.89%-21M333.65%27.97M-444.07%-11.84M-1,216.68%-23.61M
Net income from continuing operations 31.72%-22.93M67.31%-5.61M-154.56%-8.17M5.81%-12.36M117.55%3.21M20.92%-33.58M-2.14%-17.16M182.83%14.98M-222.48%-13.12M0.06%-18.28M
Depreciation and amortization -17.48%118K34.48%39K-40.54%22K-19.55%-263K7.74%320K111.63%143K101.41%29K-87.33%37K-182.71%-220K12.93%297K
Other non cash items 26.27%1.24M116.76%266K-86.80%270K-56.21%229K47,400.00%475K6,446.67%982K-53,000.00%-1.59M102,150.00%2.05M8,616.67%523K-75.00%1K
Change In working capital -963.44%-3.92M-179.05%-8.25M-45.88%5.45M4,674.17%14.42M-123.21%-15.54M-96.86%454K-214.49%-2.96M104.84%10.07M103.59%302K-145.35%-6.96M
-Change in receivables -2,083.02%-10.41M-1,592.92%-13.39M1,351.43%2.63M414.88%20.34M-483.40%-19.99M-108.20%-477K46.70%-791K70.63%-210K225.59%3.95M-130.70%-3.43M
-Change in inventory ---6.1M---3.63M---513K----------0--0--0--------
-Change in prepaid assets 253.07%3.74M223.26%959K-27.51%656K186.25%1.25M177.86%872K-965.50%-2.44M17.41%-778K-63.89%905K35.80%-1.45M-342.95%-1.12M
-Change in payables and accrued expense 877.89%15.39M251.90%9.19M701.81%3.33M78.42%-246K374.28%3.12M244.01%1.57M1,025.89%2.61M-153.94%-554K28.08%-1.14M359.68%657K
-Change in other current liabilities 7.51%-973K17.82%-166K35.74%-187K-7.42%-304K-14.49%-316K-168.71%-1.05M-109.35%-202K-66.29%-291K-21.98%-283K-23.77%-276K
-Change in other working capital -295.30%-5.56M68.22%-1.21M-104.58%-468K-499.36%-4.67M127.85%779K-66.12%2.85M-221.32%-3.8M349.63%10.22M34.92%-779K-166.53%-2.8M
Cash from discontinued investing activities
Operating cash flow 21.22%-22.43M39.42%-12.72M-105.84%-1.63M123.84%2.82M53.84%-10.9M-12.84%-28.47M-40.89%-21M333.65%27.97M-444.07%-11.84M-1,216.68%-23.61M
Investing cash flow
Cash flow from continuing investing activities -327.97%-505K-1,877.78%-178K-1,300.00%-126K-568.75%-107K-11.90%-94K-187.80%-118K-9K25.00%-9K5.88%-16K-600.00%-84K
Net PPE purchase and sale -327.97%-505K-1,877.78%-178K-1,300.00%-126K-568.75%-107K-11.90%-94K-187.80%-118K---9K25.00%-9K5.88%-16K-600.00%-84K
Cash from discontinued investing activities
Investing cash flow -327.97%-505K-1,877.78%-178K-1,300.00%-126K-568.75%-107K-11.90%-94K-187.80%-118K---9K25.00%-9K5.88%-16K-600.00%-84K
Financing cash flow
Cash flow from continuing financing activities 2,832.28%25.98M-98.80%8K076.51%-261K4,394.11%26.24M-102.13%-951K-98.20%664K113.21%107K-225.25%-1.11M-107.99%-611K
Net issuance payments of debt --0--0--0--0--041.65%-2.59M--066.61%-371K0.00%-1.11M0.00%-1.11M
Net common stock issuance 999.20%25.96M-99.85%1K--0---261K5,144.60%26.22M-95.18%2.36M-98.25%664K298.01%1.2M--0-94.29%500K
Proceeds from stock option exercised by employees --21K--7K--0--0--14K--0--0--0--0--0
Net other financing activities -----------------------720K--0------------
Cash from discontinued financing activities
Financing cash flow 2,832.28%25.98M-98.80%8K--076.51%-261K4,394.11%26.24M-102.13%-951K-98.20%664K113.21%107K-225.25%-1.11M-107.99%-611K
Net cash flow
Beginning cash position -47.44%32.73M-8.30%48.67M101.66%50.43M26.35%47.98M-47.44%32.73M44.99%62.27M31.69%53.08M-52.90%25.01M-22.18%37.97M44.99%62.27M
Current changes in cash 110.31%3.05M36.64%-12.89M-106.27%-1.76M118.93%2.45M162.73%15.25M-252.88%-29.54M-192.62%-20.35M319.41%28.07M-400.77%-12.96M-516.15%-24.3M
End cash Position 9.31%35.78M9.31%35.78M-8.30%48.67M101.66%50.43M26.35%47.98M-47.44%32.73M-47.44%32.73M31.69%53.08M-52.90%25.01M-22.18%37.97M
Free cash flow 19.78%-22.94M38.60%-12.9M-106.29%-1.76M122.91%2.72M53.60%-10.99M-13.13%-28.59M-40.95%-21.01M333.34%27.96M-446.25%-11.85M-1,212.58%-23.69M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg